Market Overview:
The global therapeutic drug monitoring market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing prevalence of chronic diseases, rising demand for personalized medicine, and technological advancements in diagnostic devices. The blood test segment is one of the largest product segments of the polyurethane market, accounting for over 50% market share in 2018. This segment is expected to grow at a CAGR of 7.8% from 2018 to 2030 due to the increasing demand for blood tests across hospitals and private laboratories. The hospital labs segment holds an important share in terms of applications with a market share of over 50% in 2018 and is expected to grow at a CAGR of 8%.
Product Definition:
Therapeutic Drug Monitoring is the use of laboratory tests to determine how much medication is in a person's blood and tissues. The information obtained from Therapeutic Drug Monitoring can help healthcare providers adjust the dose of a medication so that it remains effective but does not cause harmful side effects.
Blood Test:
Blood test is used for measuring the level of a specific substance in the blood. It's major application includes diagnosis of diseases and other health conditions. Blood tests are also used as an aid to monitor therapeutic drugs in patients undergoing treatment for chronic disease such as cancer, diabetes, etc.
Global Blood Test market by Type (Receptors, Biosensors), by Application (Diabetes Testing & Monitoring).
Urine Test:
Urine test is a diagnostic procedure that involves the analysis of urine for the presence of certain substances. Urine tests are used in therapeutic drug monitoring to monitor the metabolism and excretion rates of various drugs. Therapeutic drug monitoring helps doctors determine how long a particular medication will take to leave the body, and also whether any particular medication is being metabolized properly or not.
Application Insights:
The others segment held the largest share in 2018. This is attributed to the presence of a large number of diagnostic laboratories that offer testing services for various other applications such as cancer and autoimmune diseases. The hospital lab segment is also expected to witness lucrative growth over the forecast period due to an increase in demand for point-of-care tests at hospitals and clinics.
Therapeutic drug monitoring has been proven beneficial in managing drug therapy, improving patient compliance, reducing medication errors & adverse effects & enhancing therapeutic efficacy by detecting minimal or no response or toxicity from drugs at appropriate concentrations used during treatment. Henceforth, increasing adoption of TAMD among healthcare professionals will boost market growth over the forecast period., However, there are certain disadvantages associated with TAMD such as costliness involved in its procurement along with risks related to human error while handling samples.
Regional Analysis:
North America dominated the global market in 2018. The growth of this region can be attributed to the presence of a large number of manufacturers and distributors, availability of advanced products, high awareness among patients about TDM and its benefits along with government support for drug testing programs.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing demand for therapeutic drugs in emerging countries such as China & India. In addition, growing healthcare spending by governments coupled with rising investments by private companies will drive regional market growth over the forecast period.
In Europe therapeutic drug monitoring has been recognized as an integral part of care since it was first introduced in Germany back in 1987.
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases is increasing at an alarming rate across the globe. This is primarily because of the changing lifestyle and dietary habits of people. Therapeutic drug monitoring helps in managing these chronic diseases by providing accurate and timely information about the drug concentration in blood or other body fluids.
- Growing demand for personalized medicine: There is a growing demand for personalized medicines, which are tailored to meet the specific needs of individual patients. Therapeutic drug monitoring helps to achieve this goal by providing information about how a particular patient responds to a particular medication.
- Advances in technology: The field of therapeutic drug monitoring is constantly evolving with new advances in technology being made on a regular basis. This has led to the development of novel techniques and methods for performing therapeutic drug monitoring tests, which has helped to expand the market further.
Scope Of The Report
Report Attributes
Report Details
Report Title
Therapeutic Drug Monitoring Market Research Report
By Type
Blood Test, Urine Test, Saliva Test, Other Test, Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% market share in 2018., Therapeutic Drug Monitorin
By Application
Hospital Labs, Private Labs, Others, Hospital labs holds an important share in terms of applications with a market share of over 50% in 2018.
By Companies
Roche, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthcare, Bio-Rad Laboratories, bioMerieux, Sanquin, Becton Dickinson, Quest Diagnostics, Therapeutic Drug Monitorin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Therapeutic Drug Monitoring Market Report Segments:
The global Therapeutic Drug Monitoring market is segmented on the basis of:
Types
Blood Test, Urine Test, Saliva Test, Other Test, Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% market share in 2018., Therapeutic Drug Monitorin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Labs, Private Labs, Others, Hospital labs holds an important share in terms of applications with a market share of over 50% in 2018.
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Danaher
- Abbott
- Thermo Fisher Scientific
- Siemens Healthcare
- Bio-Rad Laboratories
- bioMerieux
- Sanquin
- Becton Dickinson
- Quest Diagnostics
- Therapeutic Drug Monitorin
Highlights of The Therapeutic Drug Monitoring Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Test
- Urine Test
- Saliva Test
- Other Test
- Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% market share in 2018.
- Therapeutic Drug Monitorin
- By Application:
- Hospital Labs
- Private Labs
- Others
- Hospital labs holds an important share in terms of applications with a market share of over 50% in 2018.
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Therapeutic Drug Monitoring Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Therapeutic drug monitoring (TDM) is a process used to continuously monitor the effects of medications in patients. TDM can help ensure that the patient is receiving the correct dosage and that any side effects are being monitored.
Some of the major companies in the therapeutic drug monitoring market are Roche, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthcare, Bio-Rad Laboratories, bioMerieux, Sanquin, Becton Dickinson, Quest Diagnostics, Therapeutic Drug Monitorin.
The therapeutic drug monitoring market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Therapeutic Drug Monitoring Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Therapeutic Drug Monitoring Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Therapeutic Drug Monitoring Market - Supply Chain
4.5. Global Therapeutic Drug Monitoring Market Forecast
4.5.1. Therapeutic Drug Monitoring Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Therapeutic Drug Monitoring Market Size (000 Units) and Y-o-Y Growth
4.5.3. Therapeutic Drug Monitoring Market Absolute $ Opportunity
5. Global Therapeutic Drug Monitoring Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Therapeutic Drug Monitoring Market Size and Volume Forecast by Type
5.3.1. Blood Test
5.3.2. Urine Test
5.3.3. Saliva Test
5.3.4. Other Test
5.3.5. Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% market share in 2018.
5.3.6. Therapeutic Drug Monitorin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Therapeutic Drug Monitoring Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Therapeutic Drug Monitoring Market Size and Volume Forecast by Application
6.3.1. Hospital Labs
6.3.2. Private Labs
6.3.3. Others
6.3.4. Hospital labs holds an important share in terms of applications with a market share of over 50% in 2018.
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Therapeutic Drug Monitoring Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Therapeutic Drug Monitoring Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Therapeutic Drug Monitoring Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Therapeutic Drug Monitoring Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Therapeutic Drug Monitoring Demand Share Forecast, 2019-2026
9. North America Therapeutic Drug Monitoring Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Therapeutic Drug Monitoring Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Therapeutic Drug Monitoring Market Size and Volume Forecast by Application
9.4.1. Hospital Labs
9.4.2. Private Labs
9.4.3. Others
9.4.4. Hospital labs holds an important share in terms of applications with a market share of over 50% in 2018.
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Therapeutic Drug Monitoring Market Size and Volume Forecast by Type
9.7.1. Blood Test
9.7.2. Urine Test
9.7.3. Saliva Test
9.7.4. Other Test
9.7.5. Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% market share in 2018.
9.7.6. Therapeutic Drug Monitorin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Therapeutic Drug Monitoring Demand Share Forecast, 2019-2026
10. Latin America Therapeutic Drug Monitoring Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Therapeutic Drug Monitoring Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Therapeutic Drug Monitoring Market Size and Volume Forecast by Application
10.4.1. Hospital Labs
10.4.2. Private Labs
10.4.3. Others
10.4.4. Hospital labs holds an important share in terms of applications with a market share of over 50% in 2018.
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Therapeutic Drug Monitoring Market Size and Volume Forecast by Type
10.7.1. Blood Test
10.7.2. Urine Test
10.7.3. Saliva Test
10.7.4. Other Test
10.7.5. Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% market share in 2018.
10.7.6. Therapeutic Drug Monitorin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Therapeutic Drug Monitoring Demand Share Forecast, 2019-2026
11. Europe Therapeutic Drug Monitoring Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Therapeutic Drug Monitoring Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Therapeutic Drug Monitoring Market Size and Volume Forecast by Application
11.4.1. Hospital Labs
11.4.2. Private Labs
11.4.3. Others
11.4.4. Hospital labs holds an important share in terms of applications with a market share of over 50% in 2018.
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Therapeutic Drug Monitoring Market Size and Volume Forecast by Type
11.7.1. Blood Test
11.7.2. Urine Test
11.7.3. Saliva Test
11.7.4. Other Test
11.7.5. Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% market share in 2018.
11.7.6. Therapeutic Drug Monitorin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Therapeutic Drug Monitoring Demand Share, 2019-2026
12. Asia Pacific Therapeutic Drug Monitoring Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Therapeutic Drug Monitoring Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Therapeutic Drug Monitoring Market Size and Volume Forecast by Application
12.4.1. Hospital Labs
12.4.2. Private Labs
12.4.3. Others
12.4.4. Hospital labs holds an important share in terms of applications with a market share of over 50% in 2018.
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Therapeutic Drug Monitoring Market Size and Volume Forecast by Type
12.7.1. Blood Test
12.7.2. Urine Test
12.7.3. Saliva Test
12.7.4. Other Test
12.7.5. Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% market share in 2018.
12.7.6. Therapeutic Drug Monitorin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Therapeutic Drug Monitoring Demand Share, 2019-2026
13. Middle East & Africa Therapeutic Drug Monitoring Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Therapeutic Drug Monitoring Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Therapeutic Drug Monitoring Market Size and Volume Forecast by Application
13.4.1. Hospital Labs
13.4.2. Private Labs
13.4.3. Others
13.4.4. Hospital labs holds an important share in terms of applications with a market share of over 50% in 2018.
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Therapeutic Drug Monitoring Market Size and Volume Forecast by Type
13.7.1. Blood Test
13.7.2. Urine Test
13.7.3. Saliva Test
13.7.4. Other Test
13.7.5. Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% market share in 2018.
13.7.6. Therapeutic Drug Monitorin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Therapeutic Drug Monitoring Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Therapeutic Drug Monitoring Market: Market Share Analysis
14.2. Therapeutic Drug Monitoring Distributors and Customers
14.3. Therapeutic Drug Monitoring Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Danaher
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Siemens Healthcare
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bio-Rad Laboratories
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. bioMerieux
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sanquin
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Becton Dickinson
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Quest Diagnostics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Therapeutic Drug Monitorin
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
